Product Details:
Strength | 5 g |
Packaging Size | 100ml |
ImmunoRel® is a solvent detergent treated, chromatographically purified immunoglobulin G(IgG) derived from pooled human plasma. The approved indications include Primary Immunodeficiency (PID), Kawasaki disease, Idiopathic Thrombocytopenic Purpura, B-cell Chronic lymphocytic leukaemia, Paediatric HIV 1 infection and Hemopoietic stem cell transplantation in elderly. The clinical experience has also shown efficacy in GB syndrome, Multifocal Motor Neuropathy, CIDP, Lambert Eaton Myasthenic syndrome, Myasthenia Gravis, Neonatal Sepsis, Polymyositis, Dermatomyositis and few others. The normal immunoglobulin is meant for intravenous use. ImmunoRel® is available in 5% concentrations in 10 ml, 20 ml, 50 ml and 100 ml pack sizes. Healthcare professionals, users and caregivers can report any adverse drug event (ADE) / adverse drug reaction (ADR), serious or non-serious, expected or un-expected, observed during usage of any product of Reliance Life Sciences. The report should contain, at the minimum, the initials of patient's name, drug name/ brand name, description of adverse event and details of the reporter. Please call on toll free number to report any adverse event. Doctors can also send the completed ADR form to the following address: Drug Safety Manager Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai, Maharashtra - 400701. The Pharmacovigilance team will revert at the earliest on receipt of the communication. Thank you for submitting the report.